Hudson Bay Capital Management’s MiMedx Group MDXG Stock Holding History

Hudson Bay Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30,000	Closed	-$192K	–	830
2018 Q2	$192K	Sell	30,000 -70,000	-70%	-$498K	﹤0.01%	743
2018 Q1	$697K	Buy	100,000 +50,000	+100%	+$582K	0.01%	639
2017 Q4	$631K	Buy	+50,000	New	+$610K	0.01%	424

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Hudson Bay Capital Management's MDXG Position: Q3 2018 in Review

Hudson Bay Capital Management sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 30,000 shares — an estimated $192K sold.

Hudson Bay Capital Management first reported a position in MDXG in Q4 2017 and held it in 3 quarters. The position peaked at $697K in Q1 2018. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

Hudson Bay Capital Management reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
Hudson Bay Capital Management sold 30,000 MiMedx Group shares in Q3 2018, an estimated $192K.
Hudson Bay Capital Management first reported a position in MiMedx Group in Q4 2017 and held it in 3 quarters.
Hudson Bay Capital Management's MiMedx Group position peaked at $697K in Q1 2018.
186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Hudson Bay Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.